VIP (Vasoactive Intestinal Peptide): A Research Overview
All information here is for laboratory and educational research only. No compound referenced is approved for human or veterinary use, and nothing here is medical advice.
- VIP (vasoactive intestinal peptide) is a natural body signaling molecule studied in immune and inflammation research.
- A synthetic version (aviptadil) has been tested in humans for lung conditions and during COVID-19; it is investigational and not FDA-approved.
- Findings come from those studies, not from BioRegen, and online discussion is unverified anecdote.
- Nothing here is approved for human use or is medical advice.
- BioRegen supplies VIP reference material strictly for laboratory and educational research, not for human use.
Vasoactive intestinal peptide, or VIP, is a small protein-like molecule built from 28 amino acids (the building blocks of proteins). It belongs to a group of molecules called neuropeptides, which the body uses to send signals. Labs that study the immune system and inflammation have shown steady interest in it. All information here is for laboratory and educational research only. No compound referenced is approved for human or veterinary use, and nothing here is medical advice. This page sums up how researchers study VIP when they look at the immune system and inflammation.
What VIP Is
VIP is part of a larger family of related signaling molecules (the secretin and glucagon family). It is found in many parts of the body, including nerves, the gut, and immune tissue. Published studies describe it as a signaling molecule that fits into specific docking points on cells called receptors. The two main ones are named VPAC1 and VPAC2. Researchers use VIP as a model molecule to learn how neuropeptides "talk" to immune cells. Any VIP material is handled only as a lab chemical, used for studies in test tubes, cell dishes, and early animal research.
Mechanism and What Research Explores
Studies have looked at how VIP sends signals through the VPAC1 and VPAC2 receptors, and at the chain of events inside immune cells that follows (one step involves a messenger molecule called cyclic AMP). In published research, scientists describe how VIP seems to shift the balance between signals that drive inflammation and signals that calm it down. They have watched this in immune cells grown in the lab, including macrophages, dendritic cells, and T cells. Because VIP appears to play several different roles at once, researchers often call it a peptide with many immune functions. None of this work proves any treatment effect. It is early, exploratory lab science aimed at understanding how the molecule works.
Research Stage and Limitations
Most VIP research on the immune system and inflammation is still at an early stage. It is done in test tubes, in cell dishes, or in animals. Results seen in cells or in animals do not tell us what would happen in people. Researchers also point out that these studies are hard to compare, because the amount of receptors present, how stable the peptide is, and the lab conditions can differ a lot from one study to the next. You may also see people mention VIP in online forums and personal stories. Those are just informal reports, not careful studies, and BioRegen does not make or back up any claim based on them.
Handling and Laboratory Notes
As a lab chemical, VIP usually comes as a dry powder (freeze-dried, which labs call lyophilized). It does not hold up well to heat, moisture, or being frozen and thawed over and over. Labs generally keep it cold and mix it back into liquid in the lab only when they are about to run a study. For a general, lab-level look at how researchers prepare peptides, see our overview on how to reconstitute peptides. These notes cover lab handling only. They are not directions for any use in people or animals.
Frequently Asked Questions
What receptors does VIP act on in research models?
In published research, VIP mainly works through two docking points on cells, called the VPAC1 and VPAC2 receptors. Scientists study these in both nerve cells and immune cells.
Why do immunology labs study VIP?
Researchers use VIP as a model molecule to understand how the nervous system and the immune system communicate, and how signaling peptides might affect inflammation in lab-grown cells and in animal studies.
Is VIP approved for any use?
No. The VIP described here is a lab chemical only. It is not approved for use in people or animals, and nothing here should be taken as medical advice.
Continue Your Research
To explore related compounds, use our research finder or browse the immunity research category. New to sourcing reference materials? Read the BioRegen research guide and create a free account for 10% off your first order.
Selected research references
- Vasoactive intestinal peptide: a neuropeptide with pleiotropic immune functions. Amino Acids, 2011.
- Vasoactive Intestinal Peptide (VIP) Protects Nile Tilapia against Infection. International Journal of Molecular Sciences, 2022.
Reference metadata sourced via PubMed.
All information on this page is provided strictly for laboratory and educational research purposes. No compound referenced is approved for human or veterinary use, none of it is intended to diagnose, treat, cure, or prevent any disease, and nothing here constitutes medical advice.